DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of Equity shares on exercise of stock options under Employee stock options scheme07-11-2023
07-11-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Intimation On Filing Of Form 6-K For The Quarter Ended September 30, 2023
Intimation on filing of Form 6-K for the quarter ended September 30, 202302-11-2023
Dr Reddy's to focus on licensing, collaborations in domestic market
Dr Reddy's Labs plans to target areas like cardiovascular, diabetes, CNS, oncology, to generate a better standard of care than the current one02-11-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of the earnings call conducted on October 27, 202301-11-2023
Neutral Dr Reddy's Labs; target of Rs 5400 : Motilal Oswal
Motilal Oswal recommended Neutral rating on Dr Reddy's Labs with a target price of Rs 5400 in its research report dated October 28, 2023.30-10-2023
Dr. Reddy's Hyderabad plant handed 10 US FDA observations
This was a routine cGMP inspection at our formulations manufacturing facility (FTO-3) in Hyderabad.30-10-2023
Dr Reddy Share Price Live blog for 30 Oct 2023
Dr Reddy stock price went down today, 30 Oct 2023, by -0.72 %. The stock closed at 5424.55 per share. The stock is currently trading at 5385.55 per share. Investors should monitor Dr Reddy stock price closely in the coming days and weeks to see how it reacts to the news.30-10-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of newspaper publication28-10-2023